Nemera is a world leader in the design, development, and manufacture of drug delivery devices for the pharmaceutical, biotech, and generics industries.
Nemera manufactures delivery devices in five main delivery route segments, of which parenteral (insulin pens, auto-injectors, and safety devices), inhalation (dry powder inhalers and pressurized metered inhalers), nasal/buccal/auricular (spray pumps, actuators, and valves), dermal (advanced airless pump-based dispensing systems) and ophthalmic (preservative-free multi-dose eye droppers).
The company addresses the needs of blue-chip customers through two different business models: contract manufacturing and proprietary devices.
Headquartered in La Verpillière (France), the company employs ca. 2,700 people across four manufacturing facilities in France, Germany, and the United States and one innovation centre across France and the United States.
Global sales
Nemera’s products are sold to a variety of blue-chip customers from the pharmaceutical, biotech and generics industries.
